On a bright and warm day of winter in Buenos Aires, in 2014, some 15 panellists met under
the rubric of (Re) thinking the bioeconomy to discuss through a reflexive and empirical lens …

In the fertility and cosmetics industries, women's body products–such as urine, eggs, and
placentas–have moved from being seen as waste to becoming valuable ingredients. Taking …

Umbilical cord blood (UCB) is an important source for stem cells used in clinical treatments.
For this purpose, UCB has to be collected at birth and stored in biobanks. The discourse …

This article builds on feminist scholarship on new biologies and the body to describe the
temporal politics of epigenetic research related to the human placenta. Drawing on …

The STS and bioethical literature on umbilical cord blood (UCB) banking nowadays
discusses the field as divided into opposite institutional arrangements, public versus private …

Twenty-three years ago when women and their children were recruited to a longitudinal
genetic epidemiological study during pregnancy, placentas were collected at birth. This …

This article appraises the late twentieth century maxim that prior to thalidomide's clarion call
in 1961, a generic “we” believed that the fetus was protected from external insult by the …

Thalassemia and leukemia and related blood disorders are approved for blood stem cell
transplants in India, for a stem cell transplant to be successful, the human leukocyte antigen …

This paper critically examines hybridity and complexity in human biobanking, focusing on
current forms of human milk banking in Madrid (Spain). We present and analyze three …

According to biological sciences, placentas are transient organs that are necessary for
mammalian fetal development and produced by interaction of maternal and fetal cells, a …